Loading...
Future Procedure Volume Risks May Limit Drug Delivery Adoption Yet Long-Term Tailwinds Remain
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
79.8%7D
-0.3%1Y
79.8%7D
-0.3%You can edit this narrative until Dec 18 9:05 PM. Then, changes will post as Updates.